天目药业
(600671)
| 流通市值：24.72亿 | | | 总市值：24.72亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 99,354,720.89 | 44,388,576.68 | 211,753,756.64 | 158,940,412.66 |
| 营业总成本 | 93,084,469.7 | 39,629,817.55 | 202,114,934.39 | 149,050,601.43 |
| 其他经营收益 | | | | |
| 营业利润 | 4,535,493.95 | 4,527,214.86 | 8,392,726.68 | 7,153,523.96 |
| 利润总额 | 8,284,233.56 | 5,934,329.43 | 10,224,391.32 | 10,001,188.74 |
| 净利润 | 4,941,350.57 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 4,941,350.57 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 243,723,468.21 | 256,591,083.88 | 228,477,096.72 | 220,539,380.5 |
| 非流动资产: | | | | |
| 非流动资产合计 | 208,347,956.27 | 208,290,926.29 | 213,553,882.53 | 209,187,926.7 |
| 资产总计 | 452,071,424.48 | 464,882,010.17 | 442,030,979.25 | 429,727,307.2 |
| 流动负债: | | | | |
| 流动负债合计 | 290,067,169.29 | 305,509,455.32 | 282,422,531.53 | 273,329,232.98 |
| 非流动负债: | | | | |
| 非流动负债合计 | 63,071,058.13 | 62,290,718.66 | 65,616,601.23 | 62,101,099.12 |
| 负债合计 | 353,138,227.42 | 367,800,173.98 | 348,039,132.76 | 335,430,332.1 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 76,308,718.29 | 73,822,606.75 | 70,006,502.39 | 66,592,681.4 |
| 股东权益合计 | 98,933,197.06 | 97,081,836.19 | 93,991,846.49 | 94,296,975.1 |
| 负债和股东权益合计 | 452,071,424.48 | 464,882,010.17 | 442,030,979.25 | 429,727,307.2 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 143,908,266.12 | 42,432,189.02 | 257,234,761.69 | 154,157,851.1 |
| 经营活动现金流出小计 | 119,621,645.19 | 61,861,702.15 | 245,443,612.45 | 184,988,939.9 |
| 经营活动产生的现金流量净额 | 24,286,620.93 | -19,429,513.13 | 11,791,149.24 | -30,831,088.8 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | - | 3,526,762.35 | 3,526,762.35 |
| 投资活动现金流出小计 | 7,583,817 | 3,564,722.06 | 34,676,854.44 | 30,163,455.66 |
| 投资活动产生的现金流量净额 | -7,583,817 | -3,564,722.06 | -31,150,092.09 | -26,636,693.31 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 135,733,973.65 | 102,353,973.65 | 163,906,300 | 120,522,800 |
| 筹资活动现金流出小计 | 116,243,056.54 | 71,401,674.84 | 165,734,700.83 | 104,420,517.31 |
| 筹资活动产生的现金流量净额 | 19,490,917.11 | 30,952,298.81 | -1,828,400.83 | 16,102,282.69 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 36,193,721.04 | 7,958,063.62 | -21,187,343.68 | -41,365,499.42 |
| 期末现金及现金等价物余额 | 62,470,368.83 | 34,234,711.41 | 26,276,647.79 | 6,098,492.05 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 36,193,721.04 | - | -21,187,343.68 | - |